Lead party: Proparco (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Good Life Pharmacy Limited (private company) · Sector: Healthcare, Pharmaceuticals · Countries of operation: Kenya, Uganda
Transaction type: Debt Financing · Asset class: Private Credit · Strategy: Direct Lending · Instrument: Debt · Deal amount: US$12m
Lead investor/buyer: Proparco · Investors/buyers: Proparco
Legal advisers: not identified in the source record.
Source: announced 2 March 2022. Original announcement: proparco.fr.


